Tempe, AZ – According to filings with the U.S. Securities and Exchange Commission, Calviri is raising $5,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Stephen Johnston played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Calviri

Calviri’s mission is to provide affordable products worldwide that will end deaths from cancer by combining a unique, highly immunogenic source of neoantigens with a peptide array platform. On our course to eradicate cancer we will develop new diagnostic and therapeutic products, and then preventative vaccines that will stop cancer from starting.

To learn more about Calviri, visit http://calviri.com/

Contact:
Stephen Johnston, Chief Executive Officer
480-205-6436
https://www.linkedin.com/in/stephen-albert-johnston-560b3126/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved